Acute inflammation |
Increased bronchial responsiveness (BHR) |
1. Changes in small airway function |
1. Reduced lung function |
∗Oedema and wall thickening |
∗Airway wall changes |
∗Airway obstruction |
∗Bronchoconstriction |
2. Alteration neural control |
2. Increase in cholinergic responsiveness |
(evidence mainly in animal models) |
∗BHR prevented by atropine |
∗Neural reflex |
∗Modulation substance P |
∗Interference M2 receptor function |
3. Induced neurogenic inflammation |
∗Sensory C fibres |
4. Potentiated cholinergic neurotransmission |
∗Disruption of epithelial barrier |
∗Increased sensitivity to constrictor agent |
∗Reduction neutral endopeptidase |
∗Increased maximal response |
3. Neutrophil recruitment and activation |
|
∗IL-8 and LTB4 production |
Interaction with airway inflammation |
4. Monocytes and macrophages |
1. Increased response to allergen (Fig. 2) |
∗Release acute phase cytokines, e.g. TNF-α |
∗Exaggerated early phase reaction |
5. Mediators |
∗Enhanced late response |
∗LTC4 and PGF2
|
∗Increased allergen penetration |
6. Decreased β-adrenergic sensitivity |
2. Potentiation inflammatory cascade |
∗Granulocytes decreased response isoprenaline |
∗Eosinophil recruitment etc. (Fig. 2) |
7. Upregulation ICAM-1 receptor |
3. Inefficient antiviral response due to type
|
∗Increased viral adhesion |
2 T-cell cytokine predominance (Fig. 1) |